Jeremy Grantham Abb Vie Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

$31.4 Billion
Q3 2024

A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Abb Vie Inc. stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 6,179 shares of ABBV stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,179

Holding current value

$1.08 Million

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $1.01 Million - $1.23 Million	6,179 New	6,179 $1.22 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $3.19 Million - $3.51 Million	-31,210 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $482,939 - $652,020	6,000 Added 23.8%	31,210 $3.34 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $2.17 Million - $2.54 Million	25,210 New	25,210 $2.21 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $1.15 Million - $1.38 Million	-18,253 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $1.2 Million - $1.53 Million	18,253 New	18,253 $1.33 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $1.5 Million - $1.85 Million	-19,253 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $23.4 Million - $26 Million	-263,200 Reduced 93.18%	19,253 $1.82 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $14.6 Million - $17.2 Million	162,253 Added 134.99%	282,453 $26.2 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $9.69 Million - $13 Million	105,300 Added 706.71%	120,200 $11.4 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $27,939 - $35,688	400 Added 2.76%	14,900 $1.32 Million
Q2 2017 Aug 14, 2017	BUY	N/A	14,500	14,500 $1.05 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track Jeremy Grantham's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Account